In parallel with lessening the viability of human U87-MG glioma cells, treatment with honokiol or TMZ individually led to cell shrinkage, caspase-3 activation, DNA fragmentation, and cell cycle arrest at the sub-G1 phase. This evidence concerns the gene CASP3 and central nervous system cancer.